Articles
Innovations in topical epidermolysis bullosa treatment: integrating advanced dressings, bioactive therapies and tissue-engineered skin
Daru. 2026 Apr 3;34(1):22. doi: 10.1007/s40199-026-00601-5. PMID: 41931158; PMCID: PMC13049120. Innovations in topical epidermolysis bullosa treatment: integrating advanced dressings, bioactive therapies and tissue-engineered skin Authors: Marwah […]Perception of Parents Regarding Oral Health-Related Quality of Life of Children With Epidermolysis Bullosa: A Cross-Sectional Study
Int J Paediatr Dent. 2026 Apr 1. doi: 10.1111/ipd.70087. Epub ahead of print. PMID: 41919311. Perception of Parents Regarding Oral Health-Related Quality of Life of Children […]Characterisation of the wound microbiome and antimicrobial resistance profiles in clinical isolates from epidermolysis bullosa patients
Orphanet J Rare Dis. 2026 Mar 7. doi: 10.1186/s13023-026-04295-5. Epub ahead of print. PMID: 41794696 Characterisation of the wound microbiome and antimicrobial resistance profiles in clinical […]Systemic inflammation in recessive dystrophic epidermolysis bullosa: a five-year longitudinal study
Br J Dermatol. 2026 Mar 5:ljag082. doi: 10.1093/bjd/ljag082. Epub ahead of print. PMID: 41787717 Systemic inflammation in recessive dystrophic epidermolysis bullosa: a five-year longitudinal study Authors: […]Zinc as a Biomarker of Nutritional Status and Clinical Burden in Recessive Dystrophic Epidermolysis Bullosa: Implications for Preventive Monitoring
Nutrients2026, 18(2), 232;https://doi.org/10.3390/nu18020232 Zinc as a Biomarker of Nutritional Status and Clinical Burden in Recessive Dystrophic Epidermolysis Bullosa: Implications for Preventive Monitoring Authors: Lucía Quintana-Castanedo1,2, Rocío Maseda1, […]An Acid-Oxidising Solution Containing Hypochlorous Acid Reduces Staphylococcus aureus and Improves Bacterial Diversity in Epidermolysis Bullosa Wounds
Exp Dermatol. 2025 Aug;34(8):e70147. doi: 10.1111/exd.70147. PMID: 40803690; PMCID: PMC12349993. An Acid-Oxidising Solution Containing Hypochlorous Acid Reduces Staphylococcus aureus and Improves Bacterial Diversity in Epidermolysis Bullosa […]An Acid-Oxidising Solution Containing Hypochlorous Acid Reduces Staphylococcus aureus and Improves Bacterial Diversity in Epidermolysis Bullosa Wounds
Exp Dermatol. 2025 Aug;34(8):e70147. doi: 10.1111/exd.70147. PMID: 40803690; PMCID: PMC12349993. An Acid-Oxidising Solution Containing Hypochlorous Acid Reduces Staphylococcus aureus and Improves Bacterial Diversity in Epidermolysis Bullosa […]“It’s like nursing a butterfly-so delicate, difficult, and unpredictable” – challenges of nurses in caring for patients with epidermolysis bullosa: a qualitative study
Orphanet J Rare Dis. 2025 Jul 23;20(1):371. doi: 10.1186/s13023-025-03925-8. PMID: 40702537. “It’s like nursing a butterfly-so delicate, difficult, and unpredictable” – challenges of nurses in caring […]Efficacy and Safety of the Topical Gene Therapy Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Study of Japanese Subjects With Dystrophic Epidermolysis Bullosa
J Dermatol. 2025 Jul 16. doi: 10.1111/1346-8138.17863. Epub ahead of print. PMID: 40667654. Efficacy and Safety of the Topical Gene Therapy Beremagene Geperpavec-svdt (B-VEC) in an […]Prevalence of Kidney Complications in a Large Cohort of Patients with Recessive Dystrophic Epidermolysis Bullosa
Br J Dermatol. 2025 Jul 15:ljaf271. doi: 10.1093/bjd/ljaf271. Epub ahead of print. PMID: 40663638 Prevalence of Kidney Complications in a Large Cohort of Patients with Recessive […]Cross-sectional analysis of wound-associated soluble factors in early, established, and chronic wounds of recessive dystrophic epidermolysis bullosa patients
Arch Dermatol Res. 2025 Jun 4;317(1):796. doi: 10.1007/s00403-025-04293-w. PMID: 40464793; PMCID: PMC12137523. Cross-sectional analysis of wound-associated soluble factors in early, established, and chronic wounds of recessive […]Staphylococcus aureus Promotes Cutaneous Lesions in Patients With Epidermolysis Bullosa
Exp Dermatol. 2025 Jun;34(6):e70129. doi: 10.1111/exd.70129. PMID: 40556416. Staphylococcus aureus Promotes Cutaneous Lesions in Patients With Epidermolysis Bullosa Authors: Qin Zeng 1, Shucui Wang 1, Nadira Nurxat 2, Xuemeng Min 3, Yanan Guo 2, Fuying Chen 1, Weitao […]Efficacy and Safety of Rigosertib in Patients with Recessive Dystrophic Epidermolysis Bullosa Associated Advanced/Metastatic Cutaneous Squamous Cell Carcinoma
Br J Dermatol. 2025 May 29:ljaf205. doi: 10.1093/bjd/ljaf205. Epub ahead of print. PMID: 40439508. Efficacy and Safety of Rigosertib in Patients with Recessive Dystrophic Epidermolysis Bullosa […]Successful Use of Upadacitinib in Treating a Child With Epidermolysis Bullosa Pruriginosa: A Case Report and Literature Review
Pediatr Dermatol. 2025 Apr 22. doi: 10.1111/pde.15963. Epub ahead of print. PMID: 40263717. Successful Use of Upadacitinib in Treating a Child With Epidermolysis Bullosa Pruriginosa: A […]Taking care of patients with recessive dystrophic epidermolysis bullosa from birth to adulthood: a multidisciplinary Italian Delphi consensus
Orphanet J Rare Dis. 2025 Mar 16;20(1):128. doi: 10.1186/s13023-025-03635-1. PMID: 40091088; PMCID: PMC11912768. Taking care of patients with recessive dystrophic epidermolysis bullosa from birth to adulthood: […]Milestone events in recessive dystrophic epidermolysis bullosa (RDEB): findings of the PEBLES Study
Clin Exp Dermatol. 2025 Jan 28:llaf009. doi: 10.1093/ced/llaf009. Epub ahead of print. PMID: 39874247. Milestone events in recessive dystrophic epidermolysis bullosa (RDEB): findings of the PEBLES […]Repurposing diacerein for the treatment of chronic wounds in recessive-dystrophic epidermolysis bullosa patients by modulating matrix metalloproteinase-9 expression
J Dermatol. 2025 Jan 24. doi: 10.1111/1346-8138.17621. Epub ahead of print. PMID: 39853777. Repurposing diacerein for the treatment of chronic wounds in recessive-dystrophic epidermolysis bullosa patients […]Prevalence of Crown Resorption in Amelogenesis Imperfecta due to Junctional Epidermolysis Bullosa
Oral Dis. 2025 Jan 8. doi: 10.1111/odi.15250. Epub ahead of print. PMID: 39777984. Prevalence of Crown Resorption in Amelogenesis Imperfecta due to Junctional Epidermolysis Bullosa Authors: […]The physical, emotional, social, and functional dimensions of epidermolysis bullosa. An interview study on burdens and helpful aspects from a patients’ perspective
Orphanet J Rare Dis. 2025 Jan 6;20(1):3. doi: 10.1186/s13023-024-03475-5. PMID: 39762901 The physical, emotional, social, and functional dimensions of epidermolysis bullosa. An interview study on burdens […]A Catheter Securement Strategy for Patients with Epidermolysis Bullosa
Advances in Skin & Wound Care 37(10):p 516-518, October 2024. | DOI: 10.1097/ASW.0000000000000216 A Catheter Securement Strategy for Patients with Epidermolysis Bullosa Authors: Strupp, Kim M. MD; Lee, Amy J. […]Pregabalin for Neuropathic Pain and Itch in Recessive Dystrophic Epidermolysis Bullosa
JAMA Dermatol. 2024 Oct 23. doi: 10.1001/jamadermatol.2024.3767. Epub ahead of print. PMID: 39441591. Pregabalin for Neuropathic Pain and Itch in Recessive Dystrophic Epidermolysis Bullosa Authors: Margarita […]Economic burden and health-related quality of life in patients with epidermolysis bullosa in Spain
Orphanet J Rare Dis. 2024 Sep 23;19(1):352. doi: 10.1186/s13023-024-03328-1. PMID: 39313783; PMCID: PMC11421099. Economic burden and health-related quality of life in patients with epidermolysis bullosa in […]Identification of novel small molecule-based strategies of COL7A1 upregulation and readthrough activity for the treatment of recessive dystrophic epidermolysis bullosa
Sci Rep. 2024 Aug 16;14(1):18969. doi: 10.1038/s41598-024-67398-8. PMID: 39152155; PMCID: PMC11329504. Identification of novel small molecule-based strategies of COL7A1 upregulation and readthrough activity for the treatment […]Rare Disease and Quality of Life: Questionnaire and Indicators on Epidermolysis Bullosa in Italy
Soc Indic Res (2024). https://doi.org/10.1007/s11205-024-03405-9 Rare Disease and Quality of Life: Questionnaire and Indicators on Epidermolysis Bullosa in Italy Authors: Mariani P, Marletta A, Zenga M Affiliation: […]Treatment of Epidermolysis Bullosa and Future Directions: A Review
Dermatol Ther (Heidelb) (2024). https://doi.org/10.1007/s13555-024-01227-8 Treatment of Epidermolysis Bullosa and Future Directions: A Review Authors: Danescu S 1, Negrutiu M1, Has C2 Affiliation: Abstract: Epidermolysis bullosa (EB) […]Efficacy of aprepitant for refractory pruritus in patients with epidermolysis bullosa and atopic dermatitis: A retrospective study
Pediatr Dermatol. 2024 Jul 25. doi: 10.1111/pde.15704. Epub ahead of print. PMID: 39049669. Efficacy of aprepitant for refractory pruritus in patients with epidermolysis bullosa and atopic […]Systematic review on antipruritic therapies for patients with Epidermolysis bullosa
J Dermatolog Treat. 2024 Dec;35(1):2381762. doi: 10.1080/09546634.2024.2381762. Epub 2024 Jul 28. PMID: 39069296. Systematic review on antipruritic therapies for patients with Epidermolysis bullosa Authors: Tobias Welponer 1, Christian […]Epidermolysis Bullosa Pruriginosa treated with baricitinib: A case report
Medicine 103(27):p e38854, July 05, 2024. | DOI: 10.1097/MD.0000000000038854 Epidermolysis Bullosa Pruriginosa treated with baricitinib: A case report Authors: He, Zhe MM1; Dong, Qian MM1; Xi, […]Developing the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES) to explore natural history and identify endpoints for the rare disease recessive dystrophic epidermolysis bullosa
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i65, https://doi.org/10.1093/bjd/ljae090.131 P104 Developing the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES) to explore natural history […]Milestone events in recessive dystrophic epidermolysis bullosa: findings from a prospective register study
British Journal of Dermatology, Volume 191, Issue Supplement_1, July 2024, Page i49, https://doi.org/10.1093/bjd/ljae090.101 P074 Milestone events in recessive dystrophic epidermolysis bullosa: findings from a prospective register study […]Evaluation of antipruritic effects of serlopitant, a neurokinin 1 receptor antagonist, in patients with epidermolysis bullosa: A phase 2 randomized controlled trial
J Eur Acad Dermatol Venereol. 2024 Jul 1. doi: 10.1111/jdv.20189. Epub ahead of print. PMID: 38949042. Evaluation of antipruritic effects of serlopitant, a neurokinin 1 receptor […]Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases
Orphanet J Rare Dis. 2024 May 21;19(1):206. doi: 10.1186/s13023-024-03190-1. PMID: 38769503; PMCID: PMC11106883. Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic […]Consensus-based Guidelines for the Provision of Palliative Care for People Living with Epidermolysis Bullosa
Orphanet J Rare Dis. 2023 Sep 4;18(1):268. doi: 10.1186/s13023-023-02870-8. PMID: 37667330; PMCID: PMC10476410. Consensus-based Guidelines for the Provision of Palliative Care for People Living with Epidermolysis […]Inpatient Management of Epidermolysis Bullosa: Consensus-Based Hands-On Instructions for Neonates and Post-Neonates.
J Am Acad Dermatol. 2024 Apr 9:S0190-9622(24)00583-8. doi: 10.1016/j.jaad.2024.04.014. Epub ahead of print. PMID: 38604489. Inpatient Management of Epidermolysis Bullosa: Consensus-Based Hands-On Instructions for Neonates and […]Orofacial Anomalies in Kindler Epidermolysis Bullosa
JAMA Dermatol. 2024 Mar 20:e240065. doi: 10.1001/jamadermatol.2024.0065. Epub ahead of print. PMID: 38506824; PMCID: PMC10955352. Orofacial Anomalies in Kindler Epidermolysis Bullosa Authors: Susanne Krämer 1 2, Anna Lena Hillebrecht 3, Yao […]Osteoporosis and bone health in pediatric patients with epidermolysis bullosa: A scoping review
Pediatr Dermatol. 2024 Jan 11. doi: 10.1111/pde.15527. Epub ahead of print. PMID: 38205535. Osteoporosis and bone health in pediatric patients with epidermolysis bullosa: A scoping review. […]Epidermolysis Bullosa
StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan Epidermolysis Bullosa [Updated 2024 Jan 11] Authors: Divya Khanna1; Ajoy Bardhan2 Affiliation: Abstract: No abstract available. Summary: Download: […]Costs of UK community care for individuals with recessive dystrophic epidermolysis bullosa: Findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study
Skin Health Dis. 2024 Jan 10;4(1):e314. doi: 10.1002/ski2.314. PMID: 38312260; PMCID: PMC10831550. Costs of UK community care for individuals with recessive dystrophic epidermolysis bullosa: Findings of […]Neonatal Epidermolysis Bullosa: a clinical practice guideline
Br J Dermatol. 2024 Jan 4:ljae006. doi: 10.1093/bjd/ljae006. Epub ahead of print. PMID: 38175636. Neonatal Epidermolysis Bullosa: a clinical practice guideline Authors: Rebecca Saad 1, José Duipmans 2, Natalie Yerlett 3, Katie […]Efficacy of oral JAK1 or JAK1/2 inhibitor for treating refractory pruritus in dystrophic epidermolysis bullosa: A retrospective case series
J Dermatol. 2023 Dec 20. doi: 10.1111/1346-8138.17079. Epub ahead of print. PMID: 38115742. Efficacy of oral JAK1 or JAK1/2 inhibitor for treating refractory pruritus in dystrophic […]Enhancing Growth in Epidermolysis Bullosa: Nutritional Supplements and Dietary Interventions for Children and Adolescents
Rev Clin Med. 2023;10(3): 32-40 Enhancing Growth in Epidermolysis Bullosa: Nutritional Supplements and Dietary Interventions for Children and Adolescents Authors: Pegah Rahbarinejad (MD)1,2, Fatemeh Sadat Hashemi […]EE553 An Exploratory Study Assessing the Utility Impact in Second Informal Carers of Patients With Epidermolysis Bullosa
Value in Health, December 2023, Volume 26, Issue 12, SupplementS1-S578, ISPOR Europe 2023 Abstracts EE553 An Exploratory Study Assessing the Utility Impact in Second Informal Carers […]Clinical and molecular features in a cohort of Middle Eastern patients with epidermolysis bullosa
Pediatr Dermatol. 2023 Oct 12. doi: 10.1111/pde.15440. Epub ahead of print. PMID: 37827535. Clinical and molecular features in a cohort of Middle Eastern patients with epidermolysis […]Assessing the epidemiological factors of epidermolysis bullosain Shiraz, the referral center of Southern Iran
JCIMCR Assessing the epidemiological factors of epidermolysis bullosain Shiraz, the referral center of Southern Iran Authors: Ali Akbar Mohammadi1,2; Nasrin Saki3,4; Mohammad Mahdi Parvizi4, Amir Hossein […]Consensus-based guidelines for the provision of palliative and end-of-life care for people living with epidermolysis bullosa
Orphanet J Rare Dis. 2023 Sep 4;18(1):268. doi: 10.1186/s13023-023-02870-8. PMID: 37667330. Consensus-based guidelines for the provision of palliative and end-of-life care for people living with epidermolysis […]Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study
Orphanet J Rare Dis. 2023 Aug 9;18(1):235. doi: 10.1186/s13023-023-02817-z. PMID: 37559055; PMCID: PMC10410928. Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study […]Epidermolysis bullosa: time to come together for better outcomes
Br J Dermatol. 2023 Jul 7;189(1):5. doi: 10.1093/bjd/ljad123. PMID: 37067920. Epidermolysis bullosa: time to come together for better outcomes Authors: Gabriela Petrof 1, Anna E Martinez 1 Affiliation: Abstract: […]Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step towards outcome harmonization
Br J Dermatol. 2023 Jul 7;189(1):80-90. doi: 10.1093/bjd/ljad077. PMID: 37098154. Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step […]BG04 Oleogel-S10 (birch triterpenes) in the treatment of epidermolysis bullosa wounds: 24-month efficacy and safety data from the EASE study
Keywords: Oleogel-S10, Amryt, AbstractABSTRACT: Compassionate use of topical beremagene geperpavec (B-VEC) for the treatment of recurrent cicatrizing conjunctivitis in a patient with dystrophic epidermolysis bullosa
Keywords: B-VEC, Krystal, Opthalmology, Gene therapy